baber/WOPTO huggingface dataset:
Patent NZ-519616-A (NZ)
Title: A portable symbol for establishing a telephone call where data and software is copied with the symbol
Inventor: DONNELLY PETER GERALD
IPC: G06Q30/06
Filed: 2000-12-22
Abstract: A symbol for establishing a telephone call, has the following characteristics: (a) the symbol appears on a computer display; (b) a user can select and activate the symbol, which causes computer software associated with the symbol to activate telecommunications equipment which establishes the telephone call; (c) the symbol is "portable", in that a user can cause it to be moved from any one of the following locations: (i) an Internet web page, (ii) an email message, (iii) a window associated with a computer program, (iv) a file directory folder, (v) and electronic form, (vi) a computer data storage medium, (vii) the user's operating system "desktop", (viii) a personal digital assistant, Wireless Application Protocol phone or other mobile computing device; to one of the following locations: (I) the user's operating system "desktop", (II) an email message, (III) a window associated with a computer program, (IV) a file directory folder, (V) an electronic form, (VI) a computer data storage medium, (VII) an Internet web page, (VIII) a personal digital assistant, Wireless Application Protocol phone or other mobile computing device; (d) when the symbol is moved from one location to another, computer software and data associated with the symbol is copied to the new location together with the symbol, the computer software and data being sufficient to facilitate the establishment of a telephone call.
Patent NZ-524948-A (NZ)
Title: A pin tumbler cylinder lock having a blocking element
Inventor: MCCARTHY BRUCE PATRICK
IPC: E05B27/04
Filed: 2002-06-19
Abstract: Disclosed is a pin tumbler cylinder lock having a blocking element (25) which extends from a body (10) of the lock into a key slot (13) in a cylinder (12) thereof to prevent full insertion and turning of any key other than the correct key (21). The shank (20) of the key (21) has its free end relieved to provide a recess (30) into which the blocking element is received, in use, when the key is inserted in the key slot and turned, thereby rotating the cylinder.
Patent NZ-527163-A (NZ)
Title: Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
Inventor: BLACKBURN THOMAS P
IPC: A61K31/404
Filed: 2002-01-31
Abstract: Disclosed are compounds of formula (I), wherein: Y1, Y2, Y3, and Y4 are independently H, alkyl, monofluoroalkyl or polyfluoroalkyl, alkenyl, cycloalkyl, cycloalkenyl, -F, -Cl, -Br, -I, -NO2, -N3, -CN, -OR4, -SR4, -OCOR4, -COR4, -NCOR4, -N(R4)2, -CON(R4)2, -COOR4, aryl, heteroaryl, or any adjacent two of Y1, Y2, Y3, and Y4 can form a methylenedioxy group, and the remaining substituents are defined herein. The compounds of formula (I) are used for the manufacture of medicaments for the treatment of depression and/or anxiety.
Patent NZ-529031-A (NZ)
Title: Resealable bag with arcuate rupturable seal
Inventor: SCHWARTZ AARON
IPC: B65D30/22
Filed: 2002-04-16
Abstract: A recloseable bag for marinading food including a flexible plastic sheet having side edges, a flexible foil sheet having side edges and sealed to the flexible plastic sheet along the edges of the sheets to form a generally rectangular bag having first and second ends and opposed sides, a recloseable closure joining the flexible plastic sheet and the flexible foil sheet adjacent the first end of the bag, and an arcuate rupturable seal extending from one opposed side to another opposed side and joining the flexible plastic sheet and the flexible foil sheet. The arcuate rupturable seal, the opposed sides, and the second end form a marinade storage compartment. A top of the arcuate rupturable seal is approximately centrally located between the opposite sides, and the recloseable closure, the opposed sides, and the second end form a food storage compartment for marinating food upon opening of the arcuate rupturable seal.
Patent NZ-530280-A (NZ)
Title: A fibre cement joint
Inventor: EKDAWI NAGI
IPC: E04C2/30
Filed: 2003-12-19
Abstract: In combination, a first and a second sheet member, each sheet member having a front and a rear major surface joined by an edge portion, the sheet members being arranged so as to have abutting edge portions, and wherein the sheet members are joined by a tape extending across the abutting edge portions and by a filler material within which the tape is substantially embedded, said tape having a YoungÆs Modulus of at least 1.8 x l03 mega pascals and wherein said edge portions include a first edge surface extending from the rear surface at an acute angle to said rear surface and a second edge surface extending from the front surface and joined to the first surface, said second surface relative to said front surface providing a depression to receive said tape and filler material to secure said sheet member to said adjacent sheet member.
Patent NZ-534856-A (NZ)
Title: Method and apparatus for preserving a beverage
Inventor: SMITH GREG
Filed: 2004-08-24
Abstract: An apparatus including: a container (1) containing inert gas at a pressure greater than atmospheric pressure; a release valve (2) allowing release of inert gas from the container; an actuator (3) allowing the release valve to be opened and closed; a first conduit (4) for carrying inert gas from the release valve; and a diffuser (5) for diffusing the gas after it is released from the release valve; wherein the first conduit and diffuser are dimensioned and configured to be inserted into a bottle and are adapted to, in use, carry inert gas from the release valve to a bottle holding a beverage to be preserved.
Patent NZ-536810-A (NZ)
Title: Denticulation of concrete joints
Inventor: LOVMO EINAR
IPC: E02B3/16
Filed: 2003-07-04
Abstract: The present invention relates to a method for denticulation of a concrete cast joint between a first and a second cast section characterised by that a studded plate is used for the formwork close of the first cast section and that the studded plate is subsequently removed before the second section is cast.
Patent NZ-538511-A (NZ)
Title: Animal identification tag with cavity for holding transponder
Inventor: WEBBER RICHARD
IPC: A01K11/00
Filed: 2003-08-26
Abstract: An animal identification tag having engagable male 2 and female 1 ends connected via a linking portion is disclosed. The male end passes through the animal's ear and into an opening 12 of the female end. The link portion includes an elongate cavity for holding a transponder 6. When the male and female ends are engaged the male end blocks the opening into which the transponder is inserted.
Patent NZ-548393-A (NZ)
Title: Nanoparticles comprising a fluorescent dye based on entrapment of a protein or DNA dye as agents for imaging finger prints
Inventor: ROWELL FREDERICK JOHN
IPC: G01N33/533
Filed: 2005-01-07
Abstract: Discloses an agent for imaging latent fingerprints comprising nanoparticles, wherein said nanoparticles comprises an intrinsic fluorescent material or a fluorescent dye selected from a protein-dye conjugate and a DNA-dye conjugate, wherein said fluorescent material or fluorescent dye is entrapped within the nanoparticle and wherein said nanoparticles are derived from a sol gel. Particularly preferred embodiments utilise cadmium sulphide or cadmium selenide nanoparticles, Texas Red labelled gelatin, porcine thyroglobulin or flurorescein-labelled bovine serum albumin. Further disclosed are methods of detecting latent fingerprints comprising the use of said nanoparticles.
Patent NZ-555047-A (NZ)
Title: Endoprosthetic elements for an ankle joint
Inventor: FELLINGER MICHAEL
IPC: A61F2/42
Filed: 2005-11-08
Abstract: A talus component 1 for a multipart ankle joint prosthesis has a bottom side 3 that faces the osseous talus after implantation which is configured as a concave spherical segment.
Patent NZ-563871-A (NZ)
Title: Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
Inventor: FRANCKOWIAK GERHARD
IPC: A61K31/198
Filed: 2006-05-20
Abstract: Disclosed is an active compound complex consisting of a salt of o-acetylsalicylic acid with a basic amino acid and glycine wherein the compound complex has a particle size distribution having a mean particle size of less than 100 micrometers. Also disclosed is the process for making the complex by rapidly combining o-acetylsalicylic acid and a basic amino acid in water or a water-miscible organic solvent at a temperature less than or equal to 40 degrees C to form a homogeneous mixture, cooling the homogeneous mixture to a temperature of from -5 to 10 degrees C, adding thereafter cooled acetone and a cooled suspension of glycine, stirring for at least one hour and isolating the crystals wherein during crystallization the temperature is not higher than 5 degrees C. Further disclosed is a solid product containing the active complex, a pharmaceutical composition comprising the active complex and the use of the active complex to prepare a medicament for the treatment of arthritis, neuralgia, myalgia, migraine, myocardial infarction, stroke, ischemic heart disease, angina pectoris, bypass operations, PTCA and stent implantation.
Patent NZ-567300-A (NZ)
Title: Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
Inventor: OHNO KOHSUKE
IPC: A61K31/381
Filed: 2006-10-17
Abstract: Disclosed is a fused heterocyclic derivative of formula (I) or a pharmaceutically acceptable salt, hydrate or solvate thereof, wherein the substituents are defined in the specification. Also disclosed is the use of the fused heterocyclic derivatives of formula (I) for the manufacture of a pharmaceutical composition for the prevention or treatment of sex hormone-dependent diseases.
Patent NZ-578335-A (NZ)
Title: A device for locking portable objects to the lug of a shipping container
Inventor: WILSON QUENTIN MACKINDER
IPC: E05B73/00
Filed: 2009-07-13
Abstract: Disclosed is a security system for locking a chain to a shipping container or other fixed object. The system includes two parts. The first part comprises a steel plate welded to the end of a bar to form a T shape. The bar has a plurality of holes along its length to accommodate the shackle of a padlock. The second part is in the form of a square plate which is perforated with a slot, thereby allowing the second part to engage with and slide along the bar. In use, the bar is inserted into the lug of a shipping container, at least one link of the chain is passed over the bar, the second part is engaged with the bar of the first part, and the shackle of the padlock engages with one of the holes of the bar preventing the chain and second part respectively from being removed from the bar.
Patent NZ-580684-A (NZ)
Title: Water treatment composition
Inventor: MORGAN ROBERT PETER
IPC: C02F1/50
Filed: 2008-05-01
Abstract: Disclosed is a composition for the treatment of water, namely aquarium water, comprising a treating component at least partially blended with a support, wherein: - The treating component is a liquid organic compound in the form of an oil; and - The support comprises a solid organic compound comprising wax. Further disclosed is a method for the treatment of water comprising adding said water treatment composition to the water.
Patent NZ-586829-A (NZ)
Title: Crystalline forms of dimethoxy docetaxel and methods for preparing same
Inventor: BILLOT PASCAL
IPC: C07D305/14
Filed: 2009-01-15
Abstract: Disclosed are crystalline forms of 4-acetoxy-2alpha-benzoyloxy-5beta-20-epoxy-1-hydroxy-7beta,10beta-dimethoxy-9-oxotax-11-en-13alpha-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate, characterized in that they are anhydrous forms. Methods for making the crystalline forms are also disclosed.
Patent NZ-590688-A (NZ)
Title: imidazo[4,5-b]pyridin-2-one derivatives
Inventor: OHTSUKA MASAMI
IPC: A61K31/4188
Filed: 2009-08-04
Abstract: Disclosed are imidazo[4,5-b]pyridin-2-one derivatives as represented by the general formula (I), wherein (R1)n-A- is a 1H-pyrrolo[2,3-b]pyridin-5-yl group, a 3-chloro-1H-pyrrolo[2,3-b]pyridin-5-yl group, a 4-chloro-1H-pyrrolo[2,3-b]pyridin-5-yl group, a 3-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl group, a 4-fluoro-1H-pyrrolo[2,3-b]pyridin-5-yl group, a 3-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl group, a 4-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl group, a 3,4-dimethyl-1H-pyrrolo[2,3-b]pyridin-5-yl group, a 3-fluoro-4-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl group or a 3-chloro-4-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl group; B is a 3- to 7-membered saturated or partially saturated monocyclic hydrocarbon group and may contain 1 or 2 oxygen atoms, sulfur atoms, nitrogen atoms, sulfinyl groups and/or sulfonyl groups as ring constituents; m is any integer of 0 to 3; Q is a bond or a C1-4 alkylene group, R3 and R4 are the same or different and are each a hydrogen atom, a halogen atom, an alkyl group, a halogeno-alkyl group or a cyano group, and R5 and R6 are the same or different and are each a hydrogen atom, a halogen atom or an alkyl group, or R5 and R6 together may form an oxo group or together with the carbon atom to which R5 and R6 are bonded may form a cycloalkyl group, or a pharmacologically acceptable salt thereof. Representative compounds include 1-[(2S)-1,4-dioxan-2-ylmethyl]-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1,3-dihydro-imidazo[4,5-b]pyridin-2-one, 1-[(2S)-1,4-dioxan-2-ylmethyl]-6-(4-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-1,3-dihydro-imidazo[4,5-b]pyridin-2-one, 2,6-anhydro-1,3,5-trideoxy-4-O-methyl-1-[6-(4-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl]-L-threo-hexitol and 2,6-anhydro-1-[6-(3-chloro-4-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl]-1,3,5-trideoxy-4-O-methyl-L-threo-hexitol. Further disclosed is a pharmaceutical composition which comprises a compound as defined above or a pharmacologically acceptable salt thereof as an active ingredient, for the manufacture of an antitumor agent, and or for the treatment of cancer.
Patent NZ-591996-A (NZ)
Title: Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug
Inventor: GRAEFE-MODY EVA ULRIKE
IPC: A61K31/155
Filed: 2009-10-15
Abstract: 591996 Disclosed is the use of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine, which is or its pharmaceutically acceptable salt for use in a method of treating and/or preventing of metabolic diseases.
Patent NZ-596855-A (NZ)
Title: Conveyor device for flat cardboard sheets in cardboard-box forming machines with a horizontal adjustable entraining loader
Inventor: BOIX JAEN JOSE
IPC: B65B35/24
Filed: 2010-12-30
Abstract: 596855 A conveyor device for flat cardboard sheets 12 in cardboard-box forming machines, comprising an encoder, a tractive mechanism, a clutch mechanism, and a horizontal entraining loader 1 including a lateral chain 2 that includes transverse pushers, cross axles 4, 4', and end pinions connected to the cross axles 4, 4'. The tractive mechanism is vertically movable and connected to the end pinions by the lateral chain 2, so that the length of the horizontal entraining loader 1 is adjusted to the sizes of the cardboard sheets 12 and to a relative location of a box forming station by varying the distance between the cross axles 4, 4', and the tension of the lateral chain 2 is maintained by varying the position of the tractive mechanism in the vertical direction. The clutch mechanism is operably coupled to the tractive mechanism to disengage transmission if a blockage occurs. The encoder is connected to the tractive mechanism and controls the position of the transverse pushers.
Patent NZ-601593-A (NZ)
Title: Progastrin and liver pathologies
Inventor: HOUHOU LEILA
IPC: G01N33/74
Filed: 2011-01-07
Abstract: Discloses a method of diagnosing whether a patient presents multiple liver pathologies (liver cancer, cirrhosis or hepatitis C), wherein a patient has been diagnosed with a first liver pathology, comprising the step of determining the human progastrin (hPG) level in a plasma or serum sample from said patient, wherein a progastrin threshold level of at least 400pM indicates that said patient is likely suffering from at least one additional liver pathology. Further discloses a method for determining a patient’s risk for a plurality of liver conditions, wherein an hPG level of between 100pM and 400pM indicates a patient is at a “high risk” for having cirrhosis with or without liver cancer, and at an “elevated risk” for also having hepatitis C.
Patent NZ-610911-A (NZ)
Title: Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same
Inventor: YACOBY-ZEEVI ORON
IPC: A61P25/16
Filed: 2011-11-15
Abstract: Disclosed is a pharmaceutically acceptable composition comprising: (i) 2.5% to 30% by weight levodopa; carbidopa; and 9% to 30% by weight arginine, wherein the composition has a pH of 8 to 10 at 25°C; or (ii) 2% to 20% by weight levodopa; 1% to 6% by weight carbidopa; and arginine, meglumine, or both arginine and meglumine, wherein the composition has a pH of 9.1 to 9.8 at 25°C. Also disclosed is the use of the composition in treatment of a neurological or movement disorder.
Patent NZ-611001-A (NZ)
Title: Container for medical accessory processing
Inventor: MASON DAVID ROBERT
IPC: B65D17/353
Filed: 2011-10-14
Abstract: A container (10) for housing a medical accessory (20) during cleaning thereof following its use on a patient is disclosed. The medical accessory may be a valve from a flexible medical endoscope. The container (10) has a closure mechanism comprising first and second complementary members (16, 17) adapted to engage with one another. Once engaged, the first and second complementary members (16, 17) cannot be disengaged from one another without the container (10) breaking. The container (10) is thus suitable only for single use, so as to prevent cross-contamination, and to comply with appropriate public health guidelines. A clip (26) is also provided so that the container may be attached to the endoscope to which the valve belongs.
Patent NZ-615728-A (NZ)
Title: Surface-cleaning device
Inventor: WOODS ETHAN
IPC: A47L9/04
Filed: 2012-11-27
Abstract: A device 10 for cleaning a surface, comprises a substantially hollow enclosure having at least a lower side, an upper side 38, and a peripheral edge, a plurality of motors each contained within the enclosure, each motor having a rotational shaft 80 fixed with a rotatable brush 60, each rotatable brush 60 having a plurality bristles radially projecting from a rotational axis 70 thereof, at least a portion of the bristles of each brush projecting below a plane of the lower side of the enclosure, a power source, and a circuit adapted for connecting power from the power source to each of the motors for a preset period of time upon actuation of an electrical switch connected thereto. The circuit is adapted to run each motor in a first direction and then an opposing direction. When the enclosure is placed upon the surface and the switch actuated, the circuit runs each motor in the first direction and then alternately in the opposing direction, such that the brushes 60 simultaneously support and move the device along the surface and clean the surface. If the enclosure becomes stuck at an obstruction it turns around due to the alternating directions of the motors
Patent NZ-617421-A (NZ)
Title: Biomarkers for hedgehog inhibitor therapy
Inventor: BANDARU RAJ
IPC: G01N33/574
Filed: 2012-04-03
Abstract: Discloses a method of predicting response to treatment with a Hedgehog signalling inhibitor, the method comprising determining the level of expression of at least two biomarkers selected from the group consisting ofGLI-1, OTX-2, SHROOM2, PDLIM3, SPHK1, SFRP1, APBA2 and SP ATA20, in a biological sample derived from a subject having cancer, thereby to predict an increased likelihood of response to a Hedgehog signalling inhibitor.
Patent NZ-620910-A (NZ)
Title: Oxide superconducting wire and superconducting coil
Inventor: DAIBO MASANORI
IPC: H01F6/06
Filed: 2013-06-10
Abstract: An oxide superconducting wire which is provided with: a superconducting laminate having a base that is in the form of a tape, and an intermediate layer, an oxide superconducting layer and a metal stabilization layer that are laminated on the base; and an insulating coating layer that covers the outer surface of the superconducting laminate. The whole of the outer surface and/or the whole of the inner surface of the insulating coating layer is covered by a coating layer that is formed of a fluororesin.
Patent NZ-624602-A (NZ)
Title: Anhydrate of tiotropium bromide
Inventor: KOKANE DATTATREY
IPC: C07D491/18
Filed: 2010-08-06
Abstract: the present disclosure relates to a novel form of anhydrous tiotropium bromide, processes for the preparation of anhydrous tiotropium bromide, pharmaceutical compositions comprising anhydrous tiotropium bromide and uses of the compositions. The anhydrous form has XPRD peaks with 29 angles of about 8.49, 11.38, 13.58, 14.24, 14.74, 16.01, 17.03, 17.93, 18.60, 19.15, 21.80, 22.62, 22.92, 23.29, 25.29, 25.57, 26.23, 27.29, 28.07, 28.61, 30.24 and 31.83 – 0.2 degrees. Further the anhydrous tiotropium bromide comprises less than 0.5% of impurity scopine di-(2-thienyl)glycolate.
Patent NZ-626483-A (NZ)
Title: The use of nicotine, analogues thereof, precursors thereof or derivatives thereof in the treatment of various pathological processes capable of improvement with a-msh administered in prophylactic or therapeutic form
Inventor: SOLIS HERRERA ARTURO
IPC: A61K31/465
Filed: 2006-05-08
Abstract: Disclosed is the use of a compound of nicotine for the manufacture of a medicament for intensifying a secretion of alpha-MSH in humans for the treatment in humans of: proliferative retinopathies where an eye fibroblasts; initial stages of retrolental fibroplasias; proliferative diabetic retinopathies; post traumatic proliferative retinopathies; proliferative retinopathies caused by hypoxia; infectious conditions or infectious syndromes to one or more of a liver, kidney, lung and blood vessels; degenerative osteoarthrosis; eclampsyia; Parkinson or Alzheimer diseases; rejection of transplanted tissues; ischemia to a kidney, lung or intestines; lipopolysaccharides deterioration to a liver or blood vessels; liver cirrhosis; cartilage protection; depression with obesity; pain relief in late term pregnancy, in the absence diabetes, hypertension or neuropathy antecedents; neonatal sepsis; or inflammatory diseases, either chronic or acute, wherein the compound of nicotine is used to intensify a secretion of alpha-MSH.
Patent NZ-703448-A (NZ)
Title: Benzimidazole-proline derivatives
Inventor: GUDE MARKUS
IPC: C07D417/14
Filed: 2013-06-03
Abstract: The present invention relates to compounds of the formula (I) wherein Ar1, R1, R2, R3, R4a, R4b and (R5)n are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as orexin receptor antagonists.